115 related articles for article (PubMed ID: 20406099)
1. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
[TBL] [Abstract][Full Text] [Related]
2. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
[TBL] [Abstract][Full Text] [Related]
4. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract][Full Text] [Related]
6. The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer.
Kontogianni P; Zambirinis CP; Theodoropoulos G; Gazouli M; Michalopoulos NV; Flessas J; Liberi M; Zografos GC
Mol Biol Rep; 2013 Jan; 40(1):43-50. PubMed ID: 23129313
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.
Ma XY; Jin Y; Sun HM; Yu L; Bai J; Chen F; Fu SB
Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1702-8. PubMed ID: 22762525
[TBL] [Abstract][Full Text] [Related]
8. The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.
Xia Y; Guo XG; Ji TX
Asian Pac J Cancer Prev; 2014; 15(6):2857-61. PubMed ID: 24761914
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1 G801A polymorphism and the risk factors for cervical cancer.
Roszak A; Misztal M; Sowińska A; Jagodziński PP
Mol Med Rep; 2015 Jun; 11(6):4633-8. PubMed ID: 25672413
[TBL] [Abstract][Full Text] [Related]
10. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
Shen W; Cao X; Xi L; Deng L
Mol Biol Rep; 2012 Feb; 39(2):2039-44. PubMed ID: 21643956
[TBL] [Abstract][Full Text] [Related]
11. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1-3'A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance.
Borghini A; Sbrana S; Vecoli C; Mercuri A; Turchi S; Carpeggiani C; L'Abbate A; Andreassi MG
J Cardiovasc Med (Hagerstown); 2014 Sep; 15(9):710-6. PubMed ID: 24751515
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
14. The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation.
Bogunia-Kubik K; Gieryng A; Dlubek D; Lange A
Bone Marrow Transplant; 2009 Sep; 44(5):273-8. PubMed ID: 19252530
[TBL] [Abstract][Full Text] [Related]
15. The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.
Zhu K; Jiang B; Hu R; Yang Y; Miao M; Li Y; Liu Z
PLoS One; 2014; 9(9):e108953. PubMed ID: 25268356
[TBL] [Abstract][Full Text] [Related]
16. Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.
Işman FK; Kucukgergin C; Daşdemir S; Cakmakoglu B; Sanli O; Seckin S
Mol Biol Rep; 2012 Dec; 39(12):11073-9. PubMed ID: 23053994
[TBL] [Abstract][Full Text] [Related]
17. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
[TBL] [Abstract][Full Text] [Related]
18. SDF1-3' a gene polymorphism is associated with laryngeal cancer.
Kruszyna L; Lianeri M; Rydzanicz M; Szyfter K; Jagodziński PP
Pathol Oncol Res; 2010 Jun; 16(2):223-7. PubMed ID: 19834823
[TBL] [Abstract][Full Text] [Related]
19. CCR2-64I polymorphism is associated with Non-Small Cell Lung Cancer in Tunisian patients.
Rafrafi A; Kaabachi S; Kaabachi W; Chahed B; Amor AB; Mbarik M; Charrad R; Salah MO; Hamzaoui K; Sassi FH
Hum Immunol; 2015 May; 76(5):348-54. PubMed ID: 25797207
[TBL] [Abstract][Full Text] [Related]
20. CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan.
Shi MD; Chen JH; Sung HT; Lee JS; Tsai LY; Lin HH
Arch Med Sci; 2013 Dec; 9(6):999-1005. PubMed ID: 24482642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
